Overview
Tempus AI operates a data-driven precision medicine platform that sequences tumor genomes and applies artificial intelligence to help oncologists make more informed treatment decisions.
More in Oncology Genomics
Adaptive Biotechnologies Corp.
Seattle, Washington, United States
Atrys
Madrid, Community of Madrid, Spain
Breast Cancer Foundation NZ
Auckland, Auckland, New Zealand
Breast Cancer Now
London, England, United Kingdom
Cancer Center of South Florida
West Palm Beach, Florida, United States
CancerIQ
Chicago, Illinois, United States
Company details
Category
🔬 Oncology Genomics
Location
Chicago, IL, USA
Funding
$1.3B+ raised; IPO 2024 (NASDAQ: TEM)
Website
www.tempus.comListed
2026-07-06
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →